Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax

Vaccination is the most effective prophylactic tool against infectious diseases. Despite continued efforts to control malaria, the disease still generally represents a significant unmet medical need. Microcrystalline tyrosine (MCT) is a well described depot used in licensed allergy immunotherapy pro...

Full description

Bibliographic Details
Main Authors: Gustavo Cabral-Miranda, Matthew D. Heath, Mona O. Mohsen, Ariane C. Gomes, Paul Engeroff, Amy Flaxman, Fabiana M. S. Leoratti, Aadil El-Turabi, Arturo Reyes-Sandoval, Murray A. Skinner, Matthias F. Kramer, Martin F. Bachmann
Format: Article
Language:English
Published: MDPI AG 2017-05-01
Series:Vaccines
Subjects:
vaccine
adjuvants
Plasmodium vivax
malaria
virus like particle (VLP)
microcrystalline tyrosine (MCT)
Online Access:http://www.mdpi.com/2076-393X/5/2/10

Similar Items

Similar Items